Tatva Chintan Pharma Chem Ltd
TATVATatva Chintan Pharma Chem Ltd
TATVA
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 80.79 | 7.20 | 0.12% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 23.81 | 3.14 | 2.85% |
Forecast & Ratings
Detailed Forecastfrom 5 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Tatva Chintan Pharma Chem is engaged in the manufacturing business of chemical products.
Investor Presentation
View olderPeers
Compare with peersGujarat Fluorochemicals Ltd
Aarti Industries Ltd
Navin Fluorine International Ltd
Vinati Organics Ltd
Clean Science and Technology Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 137.29 | 207.55 | 264.62 | 305.56 | 442.67 | 429.35 | 459.85 | |||||||
Raw Materials | 74.16 | 118.57 | 148.61 | 156.06 | 258.17 | 220.39 | 383.95 | |||||||
| Power & Fuel Cost | 4.65 | 6.25 | 8.96 | 9.92 | 22.62 | 23.61 | ||||||||
| Employee Cost | 12.27 | 16.31 | 20.53 | 23.80 | 30.82 | 38.60 | ||||||||
| Selling & Administrative Expenses | 16.15 | 25.04 | 27.15 | 30.70 | 51.97 | 47.55 | ||||||||
| Operating & Other expenses | 5.45 | 6.02 | 2.72 | 13.20 | -38.45 | 36.27 | ||||||||
EBITDA | 24.61 | 35.36 | 56.65 | 71.88 | 117.54 | 62.93 | 75.90 | |||||||
| Depreciation/Amortization | 2.95 | 4.02 | 4.79 | 6.73 | 8.18 | 9.56 | 17.70 | |||||||
| PBIT | 21.66 | 31.34 | 51.86 | 65.15 | 109.36 | 53.37 | 58.20 | |||||||
| Interest & Other Items | 2.63 | 3.95 | 4.27 | 4.45 | 5.23 | 8.60 | 11.52 | |||||||
| PBT | 19.03 | 27.39 | 47.59 | 60.70 | 104.13 | 44.77 | 46.68 | |||||||
| Taxes & Other Items | 6.75 | 6.85 | 9.81 | 8.43 | 8.25 | -0.70 | 0.80 | |||||||
| Net Income | 12.28 | 20.54 | 37.78 | 52.27 | 95.88 | 45.47 | 45.88 | |||||||
| EPS | 6.11 | 10.23 | 18.81 | 26.02 | 45.38 | 20.51 | 20.70 | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 5.00 | 2.00 | 2.00 | 2.00 | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.19 | 0.04 | 0.10 | 0.10 |
Company Updates
Peers & Comparison
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Tatva Chintan Pharma Chem Ltd | 81.52 | 7.20 | 0.12% |
| Gujarat Fluorochemicals Ltd | 23.67 | 5.70 | 0.14% |
| Aarti Industries Ltd | 38.25 | 4.24 | 0.43% |
| Navin Fluorine International Ltd | 50.16 | 8.61 | 0.32% |
Price Comparison
Compare TATVA with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 7.15%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.60%
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 1.21%
Shareholding Pattern
Mar 2023
Jun 2023
Aug 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 2.78%
Top 5 Mutual Funds holding Tatva Chintan Pharma Chem Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Nippon India ELSS Tax Saver Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.1475% | Percentage of the fund’s portfolio invested in the stock 0.89% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 54/74 (-3) |
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI MAGNUM MIDCAP FUND DIRECT PL GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.8389% | Percentage of the fund’s portfolio invested in the stock 0.73% | Change in the portfolio weight of the stock over the last 3 months -0.18% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 62/75 (-22) |
Nippon India SMALL CAP FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.4669% | Percentage of the fund’s portfolio invested in the stock 0.22% | Change in the portfolio weight of the stock over the last 3 months -0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 142/215 (-6) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 8, 2023
Dividend/Share
₹2.00
Ex DateEx Date
Sep 8, 2023
Cash Dividend
Ex DateEx DateSep 8, 2022
Dividend/Share
₹2.00
Ex DateEx Date
Sep 8, 2022
News & Opinions
Tatva Chintan gains after fixing floor price of Rs 1704.74 a share for QIP
3 months ago•Moneycontrol
News Video
Key Stocks In Focus: Paytm, Amber Enterprises, Tatva Chintan Pharma, Aurobindo Pharma, GIC RE, BEL
3 months ago•CNBC-TV18
News Video
Stocks To Trade | Tatva Chintan और Hindustan Aeronautics को Portfolio में जोड़ने का फायदा?
3 months ago•CNBC Awaaz.
IdeaForge lists at 94% above its IPO price
5 months ago•Economic Times
Tatva Chintan surges 4% as board to consider fund-raise on July 11
5 months ago•Moneycontrol
Tatva Chintan Pharma drops 8% as margin disappoints
7 months ago•Moneycontrol
Tatva Chintan Pharma Chem shares tank 5% after Q3 results; what’s next: Rs 1,950 or Rs 2,200?
10 months ago•Business Today
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 25.61%, vs industry avg of 9.75%
Increasing Market Share
Over the last 5 years, market share increased from 0.27% to 0.47%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 29.93%, vs industry avg of 18.49%